These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7959929)

  • 1. Effect of Ep475 on changes induced by calcium activated neutral protease on erythrocyte membrane.
    Devi CV; Anandaraj MP
    Indian J Exp Biol; 1994 Jul; 32(7):511-2. PubMed ID: 7959929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of calcium-activated neutral protease (calpain) in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition.
    Atsma DE; Bastiaanse EM; Jerzewski A; Van der Valk LJ; Van der Laarse A
    Circ Res; 1995 Jun; 76(6):1071-8. PubMed ID: 7758161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-induced localization of calcium-activated neutral proteinase on plasma membranes.
    Sakai K; Hayashi M; Kawashima S; Akanuma H
    Biochim Biophys Acta; 1989 Oct; 985(1):51-4. PubMed ID: 2551388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca(2+)-activated neutral protease is active in the erythrocyte membrane in its nonautolyzed 80-kDa form.
    Molinari M; Anagli J; Carafoli E
    J Biol Chem; 1994 Nov; 269(45):27992-5. PubMed ID: 7961733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of intracellular calcium-activated neutral proteinase in erythrocytes and its inhibition by exogenously added inhibitors.
    Hayashi M; Inomata M; Saito Y; Ito H; Kawashima S
    Biochim Biophys Acta; 1991 Sep; 1094(3):249-56. PubMed ID: 1911875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
    Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocation of human platelet calpain-I.
    Ariyoshi H; Shiba E; Sakon M; Kambayashi J; Yoshida K; Kawashima S; Mori T
    Biochem Mol Biol Int; 1993 May; 30(1):63-72. PubMed ID: 8358337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the calpain inhibitor E64-d on platelet activation responses.
    Patel Y; Wheeler-Jones CP; Sadowska K; Kakkar VV; Krishnamurthi S
    Br J Pharmacol; 1989 Dec; 98 Suppl():846P. PubMed ID: 2558770
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetic state-induced activation of calcium-activated neutral proteinase in mouse skeletal muscle.
    Kobayashi S; Fujihara M; Hoshino N; Kimura I; Kimura M
    Endocrinol Jpn; 1989 Dec; 36(6):833-44. PubMed ID: 2561275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between plasma membrane (Ca+Mg) ATPase and calpain/calpastatin system in rat erythrocytes.
    Soldati L; Vezzoli G; Salardi S; Spaventa R; Barber BR; Azzani T; Bianchi G
    Biochem Biophys Res Commun; 1996 May; 222(2):572-5. PubMed ID: 8670246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of myelin basic protein by calcium-activated neutral protease (CANP) in human brain and inhibition by E-64 analogue.
    Yanagisawa K; Sato S; Amaya N; Miyatake T
    Neurochem Res; 1983 Oct; 8(10):1285-93. PubMed ID: 6197665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of activity of calcium activated neutral protease.
    Suzuki K; Imajoh S; Emori Y; Kawasaki H; Minami Y; Ohno S
    Adv Enzyme Regul; 1988; 27():153-69. PubMed ID: 2854947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of erythrocyte membrane binding and autolytic activation of calcium-activated neutral protease.
    Inomata M; Hayashi M; Nakamura M; Saito Y; Kawashima S
    J Biol Chem; 1989 Nov; 264(31):18838-43. PubMed ID: 2553723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-activated neutral protease (CANP), a putative processing enzyme of the neuropeptide, kyotorphin, in the brain.
    Yoshihara Y; Ueda H; Imajoh S; Takagi H; Satoh M
    Biochem Biophys Res Commun; 1988 Sep; 155(2):546-53. PubMed ID: 2844173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitor of calcium activated neutral proteinase is an anti-meiotic agent. The spermicidal and anti-viral action.
    Logothetou-Rella H
    Histol Histopathol; 1995 Apr; 10(2):271-82. PubMed ID: 7599427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of a new component of the Ca(2+)-dependent proteolytic system in rat brain: the calpain activator.
    Melloni E; Michetti M; Salamino F; Sparatore B; Pontremoli S
    Biochem Biophys Res Commun; 1998 Aug; 249(3):583-8. PubMed ID: 9731179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain.
    Wang S; Peng Q; Zhang J; Liu L
    Cardiovasc Res; 2008 Nov; 80(2):255-62. PubMed ID: 18591204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of the small (30K) subunit of calcium-activated neutral protease (CANP).
    Suzuki K; Emori Y; Ohno S; Imahori S; Kawasaki H; Miyake S
    Biomed Biochim Acta; 1986; 45(11-12):1487-91. PubMed ID: 3034236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of calcium-activated neutral proteinase (CANP) inhibitors for human mu CANP and mCANP.
    Saito K; Nixon RA
    Neurochem Res; 1993 Feb; 18(2):231-3. PubMed ID: 8474564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical ablation induces a spreading calcium-dependent, secondary pathogenesis which can be reduced by inhibiting calpain.
    Bartus RT; Chen EY; Lynch G; Kordower JH
    Exp Neurol; 1999 Feb; 155(2):315-26. PubMed ID: 10072307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.